Skip to content
MarketScale
‹ Back to IndustriesHealthcare

President Biden’s National Drug Control Strategy

The opioid crisis in the United States is on the rise. Overdose deaths continue to escalate, even with increased measures to curtail illegal access to subscription medication. The CDC estimates annual overdose deaths top 100,000.  On April 21, 2022, President Biden provided Congress with his administration’s first National Drug Control Strategy. The strategy focuses on…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

The opioid crisis in the United States is on the rise. Overdose deaths continue to escalate, even with increased measures to curtail illegal access to subscription medication. The CDC estimates annual overdose deaths top 100,000. On April 21, 2022, President Biden provided Congress with his administration’s first National Drug Control Strategy. The strategy focuses on two drivers of the epidemic: untreated addiction and drug trafficking.

 
Eliminating Illegal Drugs Does Not Eliminate Addiction

The President’s Drug Control Strategy proposes several methods for reducing domestic and international drug production and trafficking, including increased border protection and $300 million in the Drug Enforcement Administration’s budget. How much of an impact will these efforts make? It is impossible to determine at present, but Dr. Michael Sprintz, Founder and CEO of the Sprintz Center for Pain, pointed out that even if the United States could eliminate all illegal drugs coming across its borders, drug addiction would not simply go away.

“Eliminating the supply does not change the demand,” said Dr. Michael Sprintz. “We saw this play out as the DEA decreased the availability of prescription opioids, and yet what happened was the demand for opioids from people with addictive disease didn’t decrease.”

Harm reduction efforts are another important component in the fight against addiction, as the availability of fentanyl and other synthetic drugs make overdoses more common and more deadly. In 2020, the U.S. attributed 56,516 overdose deaths to synthetic opioids (primarily fentanyl.) Increasing the availability of life-saving drugs like NARCAN® and safe needle-exchange programs will help save lives. Still, harm reduction efforts do not solve the core problem, which is treating the addiction and getting patients the care they need to recover.

 
It’s Not Just About Getting Access to Care

Increasing access to care is a welcomed part of the Biden plan, but care, in and of itself, is not a total solution. “It’s about having access to evidence-based, affordable care,” Dr. Sprintz said. “You can have access to care to get treatment for a substance abuse problem, but if you can’t afford it, it doesn’t matter that you have access to it.”

Affordable, available, and successful treatment services are paramount to stopping addiction in this country. “If we don’t have treatment services to help people not just get sober, but stay sober, to give them the tools to help them cope with life on life’s terms, then we’re screwed,” Dr. Sprintz said.

The efforts to make more affordable treatment services available to people suffering from addiction is what Dr. Sprintz believes is the most important takeaway from the Biden drug control strategy. “We need to give access to care to as many people as we can and do it in a way that we can afford it.”

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Connected Across Texas - Leah Barton

The article discusses healthcare connectivity efforts in Texas, focusing on Healthconnect TX's role. Connectivity is emphasized as crucial for efficient healthcare service delivery in the region.

  • 01Healthcare connectivity is vital for efficient service delivery.
  • 02Healthconnect TX is working to enhance healthcare connectivity in Texas.

Aug 18, 2026

Health tech AI investment is accelerating into chronic care, home health, and workforce training in 2026

Health tech AI investment is accelerating into chronic care, home health, and workforce training in 2026

Investment in health tech AI is increasing, with significant funding directed towards chronic care, home health, and workforce training. In June, there were four major funding rounds totaling $335 million aimed at improving these areas. The focus includes AI scheduling and home care operations.

  • 01Four major health tech funding rounds totaling $335 million were closed in June.
  • 02Investments are targeting chronic disease management, AI scheduling, and home care operations.
  • 03Workforce training in the healthcare sector is a key area receiving funding.

Aug 18, 2026

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512